Cargando…

Case of olmesartan-associated enteropathy and transient positive antitissue transglutaminase serology

Olmesartan-associated enteropathy (OAE) is increasingly being recognised as a major differential diagnosis in patients with villous atrophy and negative coeliac disease (CD) serology. OAE and positive coeliac markers have rarely been reported. We report a case of diarrhoea and small bowel villous bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghaith, Jenan, Raslan, Ismail A, Szilagyi, Andrew, Alameldin, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301511/
https://www.ncbi.nlm.nih.gov/pubmed/30567230
http://dx.doi.org/10.1136/bcr-2018-225518
Descripción
Sumario:Olmesartan-associated enteropathy (OAE) is increasingly being recognised as a major differential diagnosis in patients with villous atrophy and negative coeliac disease (CD) serology. OAE and positive coeliac markers have rarely been reported. We report a case of diarrhoea and small bowel villous blunting associated with a transient elevation of antitissue transglutaminase antibody (ATTG). On discontinuation of olmesartan, symptoms improved, repeat biopsies were normal and levels of ATTG also returned normal. We discuss a possible explanation for the transient elevation in ATTG and the significance of considering OAE/CD overlap.